Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 8-K Event Other events
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 10-K Report Annual Report
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Other events
  11. 10-Q Report Quarterly Report
  12. 8-K Event Other events
  13. SC 13G Stake Amended Statement of Ownership
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 8-K Event Delisting notice
  19. 8-K Event Exit or restructuring costs · Executive or director change · Other events
  20. SC 13D/A Stake Beneficial Ownership Report

Page 8 of 18 · 353 filings